KIITEE Phase 1 Admit Card 2025: Kalinga Institute of Industrial Technology (KIIT) has released the admit card and opened the slot booking process for the KIITEE 2025 Phase 1 examination. Candidates ...

YANTAI, China, April 8, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym ...

Credit: Getty Images In a phase 3 clinical trial, researchers assessed the efficacy and safety of inebilizumab in patients with generalized myasthenia gravis. At Week 26, compared to the placebo ...

Rhythm Phar­ma­ceu­ti­cals is look­ing to ex­pand the po­ten­tial mar­ket for its rare obe­si­ty treat­ment Im­civree be­yond ge­net­ic dis­or­ders.

When the Paul Skenes’ MLB Debut Auto Patch Card sold for more than $1 million ... news and more from Rounds 2, 3 as Shedeur Sanders waits to be drafted The 2025 NFL Draft is officially underway ...

Cassava Sciences will discontinue developing simufilam for mild to moderate Alzheimer’s disease by the end of the second quarter of this year after the experimental treatment failed to meet key Phase ...

Roche on Thurs­day shared ear­ly pos­i­tive re­sults for its Alzheimer’s can­di­date tron­tinemab, the lat­est round of da­ta in its sec­ond at­tempt to de­vel­op a drug … ...

As a once-daily oral therapy, based on the data from this study, ICP-488 will be “a valuable treatment option for moderate to severe plaque psoriasis” if phase 3 data confirm these findings ...

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...

A total of 209 patients received upadacitinib at a dose of 15 mg, 107 received upadacitinib at a dose of 7.5 mg, and 112 received placebo; 70% of the patients had new-onset giant-cell arteritis ...

The Company is currently evaluating lanifibranor, a novel pan-PPAR agonist, in the NATiV3 pivotal Phase 3 clinical trial for the treatment of adult patients with MASH, a common and progressive chronic ...

More recent figures are available on this topic. View the latest figures here. © CBS / Nikki van Toorn The inflation rate in the Netherlands stood at 3.7 percent in ...